Compare POWL & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | POWL | AMRX |
|---|---|---|
| Founded | 1947 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.0B |
| IPO Year | 1995 | 2018 |
| Metric | POWL | AMRX |
|---|---|---|
| Price | $498.50 | $11.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $427.00 | $14.75 |
| AVG Volume (30 Days) | 194.3K | ★ 1.8M |
| Earning Date | 05-11-2026 | 05-15-2026 |
| Dividend Yield | ★ 0.21% | N/A |
| EPS Growth | 20.91 | ★ 157.89 |
| EPS | ★ 3.40 | 0.22 |
| Revenue | ★ $448,716,000.00 | N/A |
| Revenue This Year | $9.66 | $6.40 |
| Revenue Next Year | $6.61 | $6.54 |
| P/E Ratio | $151.23 | ★ $55.07 |
| Revenue Growth | ★ 13.34 | N/A |
| 52 Week Low | $153.30 | $6.69 |
| 52 Week High | $612.50 | $15.42 |
| Indicator | POWL | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.42 | 21.37 |
| Support Level | $476.00 | $11.55 |
| Resistance Level | $612.50 | $12.12 |
| Average True Range (ATR) | 27.78 | 0.49 |
| MACD | -7.66 | -0.26 |
| Stochastic Oscillator | 23.91 | 0.00 |
Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.